Implementing sustainable, stage-appropriate measures

In everyday life, the hands are subject to high levels of stress and are therefore also exposed. Hand eczema is one of the most common clinical pictures in dermatological and occupational medicine settings. Chronic forms are common, usually due to a multifactorial etiology. While alitretinoin was the only approved systemic treatment for moderate to severe chronic hand eczema for a long time, the treatment spectrum has now been expanded with the market approval of the topical JAK inhibitor delgocitinib.